D-29
Today is 2022. 08. 17

Scientific Program

  • Home
  • Program
  • Scientific Program

※Some lectures will be pre-recorded.

September 15(Thu)
12:50 - 14:20
Symposium 1
Optimal risk factor control in patients with DM
September 15(Thu) 12:50 - 14:20
Symposium 1
Optimal risk factor control in patients with DM

Chairperson

Jeong Taek Woo (Kyung Hee University, Korea), Young Joon Hong (Chonnam National University, Korea)

Panels

Shin Ae Kang (Yonsei University, Korea), Ik Jun Choi (The Catholic University of Korea, Korea)

12:50 - 13:10

How much treatable residual risk do we really have?

Bo Kyung Koo (Seoul National University, Korea)

13:10 - 13:30

Concept of multiple risk factor control in DM

Hyun Min Kim (Chung-Ang University, Korea)

13:30 - 13:50

Is there special tool for control of diabetic dyslipidemia?

Nam Hoon Kim (Korea University, Korea)

13:50 - 14:15

Discussion

September 15(Thu)
15:30 - 17:00
Symposium 4
Update on coronary CT: risk marker, monitoring tool & future perspective
September 15(Thu) 15:30 - 17:00
Symposium 4
Update on coronary CT: risk marker, monitoring tool & future perspective

Chairperson

Cheol-Young Park (Sunkyunkwan University, Korea), Youngkeun Ahn (Chonnam National University, Korea)

Panels

Chul-Ung Choi (Korea University, Korea), Eun Ju Chun (Seoul National University, Korea)

15:30 - 15:50

Calcium score to predict future CV event

Eun-Jung Rhee (Sungkunkwan University, Korea)

15:50 - 16:10

What are unsolved issues in the coronary CT research?

Iksung Cho (Yonsei University, Korea)

16:10 - 16:30

New markers of coronary CT for future CV event

Min Jae Cha (Chung-Ang University, Korea)

16:30 - 16:55

Discussion

Breakfast & Luncheon Symposium
September 15(Thu)
12:00 - 12:50
Luncheon Symposium 1 [Daewoong]
September 15(Thu) 12:00 - 12:50
Luncheon Symposium 1 [Daewoong]

Chairperson

Donghoon Choi (Yonsei University, Korea)

Panels

Jae-Youn Moon (CHA University, Korea), Jun Sung Moon (Yeungnam University, Korea)

12:00 - 12:20

Atorvastatin with ezetimibe combination therapy for very high/high risk groups

Seung Pyo Lee (Seoul National University, Korea)

12:20 - 12:30

Discussion

September 15(Thu)
12:50 - 14:20
Basic Research Workshop 1
Lipid metabolism & metabolic disorders
September 15(Thu) 10:00 - 10:50
Basic Research Workshop 1 Lipid metabolism & metabolic disorders

Chairperson

Young Mi Park (Ewha Womans University, Korea), TBD

Panels

Hyun Duk Jang (Seoul National University, Korea), Kyung-Sun Heo (Chungnam National University, Korea)

12:50 - 13:10

Cellular lipid trafficking & cholesterol homeostasis

Young Mi Park (Ewha Womans University, Korea)

13:10 - 13:30

Identification of novel lipid droplet factors in macrophage foam cells

Mireille Ouimet (University of Ottawa, Canada)

13:30 - 13:50

Nutrient sensing mechanism for LDLR related protein LRP6

Eek-hoon Jho (University of Seoul, Korea)

13:50 - 14:15

Discussion

September 15(Thu)
14:30 - 15:30
Oral Presentation 1 (APSAVD Young Investigator Session)
September 15(Thu) 14:30 - 15:30
Oral Presentation 1 (APSAVD Young Investigator Session)

Chairperson

Chul-Ung Choi (Korea University, Korea)

14:30 - 14:37

A novel molecular diagnostic prototype for detection of pathogenic familial hypercholesterolaemia variants in an Asian population

Norhidayah Rosman (AIMST University, Malaysia)

14:37 - 14:44

Apolipoprotein CIII deficiency exacerbates diet-induced fatty liver & insulin resistance in knock-out rabbits

Xiangming Tang (University of Yamanashi, Japan)

14:44 - 14:51

PCSK9 inhibitors exhibit attenuation of biomarkers of endothelial activation & oxidative stress in human coronary artery endothelial cells

Rahayu Zulkapli (Universiti Teknologi MARA, Malaysia)

14:51 - 14:58

Comparison of on-statin lipid & lipoprotein levels for residual cardiovascular risk prediction in type 2 diabetes

Ji Yoon Kim (Korea University, Korea)

September 15(Thu)
15:30 - 17:00
Basic Research Workshop 2
SMC plasticity in plaque stability
September 15(Thu) 15:30 - 17:00
Basic Research Workshop 2 SMC plasticity in plaque stability

Chairperson

Jae-Ryong Kim (Yeungnam University, Korea)

Panels

Soyeon Lim (Catholic Kwandong University, Korea), Yong Sook Kim (Chonnam National University, Korea)

15:30 - 15:50

Role of TCF21 disease gene in SMC phenotype modulation

Juyong Brian Kim (Stanford University, USA)

15:50 - 16:10

Targeting SMC phenotypic switching in vascular disease

Chang-Seon Myung (Chungnam National University, Korea)

16:10 - 16:30

Regulation of phenotypic plasticity of vascular smooth muscle cells

Sun Sik Bae (Pusan National University, Korea)

16:30 - 16:55

Discussion

Breakfast & Luncheon Symposium
September 15(Thu)
12:00 - 12:50
Luncheon Symposium 2 [Chong Kun Dang]
September 15(Thu) 12:00 - 12:50
Luncheon Symposium 2 [Chong Kun Dang]

Chairperson

Jaetaek Kim (Chung-Ang University, Korea)

Panels

Ji Woong Roh (Yonsei University, Korea), Sangmo Hong (Hanyang University, Korea)

12:00 - 12:20

How to manage cardiovascular health with atorvastation in patients

Hyungdon Kook (Hanyang University, Korea)

12:20 - 12:30

Discussion

September 15(Thu)
12:50 - 14:20
Symposium 2
Novel risk factors & intervention targets in atherosclerosis
September 15(Thu) 12:50 - 14:20
Symposium 2 Novel risk factors & intervention targets in atherosclerosis

Chairperson

Moon-Kyu Lee (Eulji University, Korea), Mahmood Hussain (New York University, USA)

Panels

Jong-Chan Youn (The Catholic University of Korea, Korea), Yoo-wook Kwon (Seoul National University, Korea)

12:50 - 13:10

Biological & clinical influence of air pollution on metabolism & vasculature

Seung-Pyo Lee (Seoul National University, Korea)

13:10 - 13:30

Role of T-cell cholesterol efflux pathways in aging, inflammation, & atherosclerosis

Marit Westerterp (University of Groningen, Netherlands)

13:30 - 13:50

Circadian rhythm as risk & treatment target in ASCVD

Mahmood Hussain (New York University, USA)

13:50 - 14:15

Discussion

September 15(Thu)
12:50 - 14:20
Symposium 3
NAFLD, metabolic dysfunction & ASCVD
September 15(Thu) 12:50 - 14:20
Symposium 3 NAFLD, metabolic dysfunction & ASCVD

Chairperson

Youngmi Kim (Kyung Hee University, Korea), Byung Wan Lee (Yonsei University, Korea)

Panels

Hye-Jin Yoo (Korea University, Korea), Chang-Yeon Kim (Daegu Catholic University, Korea)

12:50 - 13:10

MAFLD & risk of cardiovascular disease

Yong-ho Lee (Yonsei University, Korea)

13:10 - 13:30

The role of mitochondrial enzyme PDK in the pathogenesis of NAFLD & ASCVD

Jae-Han Jeon (Kyungpook National University, Korea)

13:30 - 13:50

Recent evidence between CVD & NAFLD/NASH in Japan

Masahiro Koseki (Osaka University, Japan)

13:50 - 14:15

Discussion

September 15(Thu)
15:30 - 17:00
Symposium 5
Lipid as risk & target in cerebrovascular disease
September 15(Thu) 15:30 - 17:00
Symposium 5 Lipid as risk & target in cerebrovascular disease

Chairperson

Sang-Ho Jo (Hallym University, Korea), Sun U. Kwon (University of Ulsan, Korea)

Panels

Hoyoun Won (Chung-Ang University, Korea), Jeong-Min Kim (Seoul National University, Korea)

15:30 - 15:50

Lipid management for patients with non-atherosclerotic stroke

Woo-Keun Seo (Sungkyunkwan University, Korea)

15:50 - 16:10

Target LDL-C level for patients with cerebrovascular disease

Kazuo Kitagawa (Tokyo women's medical hospital, Japan)

16:10 - 16:30

The next step in stroke prevention: beyond lowering LDL cholesterol

Yong-Jae Kim (The Catholic University of Korea, Korea)

16:30 - 16:55

Discussion

September 16(Fri)
09:00 - 09:40
Plenary Lecture 1
September 16(Fri) 09:00 - 09:40
Plenary Lecture 1

Chairperson

Donghoon Choi (Yonsei University, Korea)

09:00 - 09:40

Target discovery & drug development for atherosclerosis in 2020's

Sekar Kathiresan (Verve therapeutics, USA)

September 16(Fri)
09:45 - 11:15
Symposium 6
Adipose tissue & atherosclerosis
September 16(Fri) 09:45 - 11:15
Symposium 6 Adipose tissue & atherosclerosis

Chairperson

Junghyun Noh (Inje University, Korea), Jin Han (Inje University, Korea)

Panels

Sung-Wan Chun (Soonchunhyang University, Korea), Nam Hoon Kim (Korea University, Korea)

09:45 - 10:05

Novel mechanisms for lipogenesis regulation

Gina Lee (University of California Irvine, USA)

10:05 - 10:25

Local & systemic effect of organ fat deposition

Sung Hee Choi (Seoul National University, Korea)

10:25 - 10:45

Sex-dependent NAD+ metabolism in the liver and adipose tissue

Ji-Young Lee (University of Connecticut, USA)

10:45 - 11:10

Discussion

September 16(Fri)
11:30 - 12:00
Plenary Lecture 2 (APSAVD:Ding Lecture)
September 16(Fri) 11:30 - 12:00
Plenary Lecture 2 (APSAVD:Ding Lecture)

Chairperson

Richard O’Brien (University of Melbourne, Australia)

11:30 - 12:00

Recent developments in the treatment of familial hypercholesterolaemia & other familial lipid disorders

Brian Tomlinson (Macau University of Science & Technology, China)

September 16(Fri)
12:55 - 13:35
Plenary Lecture 3
September 16(Fri) 12:55 - 13:35
Plenary Lecture 3

Chairperson

Goo Taeg Oh (Ewha Womans University, Korea)

12:55 - 13:35

Senescence & vascular smooth muscle cell plasticity

Martin Bennett (University of Cambridge, UK)

September 16(Fri)
13:35 - 15:05
Symposium 10
Debate on developing risk grouping in Korea: current status, comparison with foreign, & solution
September 16(Fri) 13:35 - 15:05
Symposium 10 Debate on developing risk grouping in Korea: current status, comparison with foreign, & solution

Chairperson

Myung Ho Jeong (Chonnam National University, Korea), Sung Rae Kim (The Catholic University of Korea, Korea)

Panels

Jae Hyoung Park (Korea University, Korea), Kyung-Soo Kim (CHA University, Korea)

13:35 - 13:55

Current evidence on risk stratifying factors in Koreans

Ji Hye Huh (Hallym University, Korea)

13:55 - 14:15

How much different event risk do Koreans have compared to European descendants?

Song Vogue Ahn (Ewha Womans University, Korea)

14:15 - 14:35

How to select of low risk individuals to avoid pharmacotherapy?

Hack-Lyoung Kim (Seoul National University, Korea)

14:35 - 15:00

Discussion

September 16(Fri)
15:15 - 16:15
Oral Presentation 2
September 16(Fri) 15:15 - 16:15
Oral Presentation 2

Chairperson

Yoo-wook Kwon (Seoul National University, Korea), TBD

September 16(Fri)
16:15 - 17:45
Symposium 13
Debate on new Korean guidelines on dyslipidemia: treatment
September 16(Fri) 16:15 - 17:45
Symposium 13 Debate on new Korean guidelines on dyslipidemia; treatment

Chairperson

Chee Jeong Kim (Chung-Ang University, Korea), Hak Chul Jang (Seoul National University, Korea)

Panels

In-Kyung Jeong (Kyung Hee University, Korea), Byung Jin Kim (Sungkyunkwan University, Korea)

16:15 - 16:35

Korean evidence on target LDL-C levels

Min Kyong Moon (Seoul National University, Korea)

16:35 - 16:55

Are current Western LDL-C targets for each risk groups cost-effective in Koreans?

Sang-Hyun Kim (Seoul National University, Korea)

16:55 - 17:15

When is clinically appropriate to start anti-PCSK9 Abs?

Chang-Wook Nam (Keimyung University, Korea)

17:15 - 17:40

Discussion

Breakfast & Luncheon Symposium
September 16(Fri)
08:00 - 09:00
Breakfast Symposium 1 [Celltrionpharm]
September 16(Fri) 08:00 - 09:00
Breakfast Symposium 1 [Celltrionpharm]

Chairperson

Woo Je Lee (University of Ulsan, Korea)

Panels

Ji Yong Jang (National Health Insurance Service Ilsan Hospital, Korea), Ji A Seo (Korea University, Korea)

08:00 - 08:20

Benefits of insulin sensitizer; atherosclerosis & stroke

Junghyun Noh (Inje University, Korea)

08:20 - 08:30

Discussion

September 16(Fri)
12:00 - 12:50
Luncheon Symposium 3 [Organon]
September 16(Fri) 12:00 - 12:50
Luncheon Symposium 3 [Organon]

Chairperson

Hong Kyu Lee (Seoul National University, Korea)

Panels

Hyuck Jun Yoon (Keimyung University, Korea), Seung Jin Han (Ajou University, Korea)

12:00 - 12:20

Recent Update on Combination Therapy for High risk ASCVD patients

Jong-Chan Youn (The Catholic University of Korea, Korea)

12:20 - 12:30

Discussion

September 16(Fri)
09:00 - 09:40
Plenary Lecture 1
September 16(Fri) 09:00 - 09:40
Plenary Lecture 1

Chairperson

Donghoon Choi (Yonsei University, Korea)

09:00 - 09:40

Target discovery & drug development for atherosclerosis in 2020's

Sekar Kathiresan (Verve therapeutics, USA)

September 16(Fri)
09:45 - 11:15
Symposium 7
New regulators of dyslipidemia & atherosclerosis
September 16(Fri) 09:45 - 11:15
Symposium 7 New regulators of dyslipidemia & atherosclerosis

Chairperson

Soon Jun Hong (Korea University, Korea), In Kyeom Kim (Kyungpook National University, Korea)

Panels

Eun Hee Koh (University of Ulsan, Korea), Pilhan Kim (KAIST, Korea)

09:45 - 10:05

Validation of metabolic targets in adipose tissue for ASCVD

Mete Civelek (University of Virginia, USA)

10:05 - 10:25

Deficiency of myeloid PHD proteins aggravates atherogenesis via macrophage apoptosis & paracrine fibrotic signalling

Judith Sluimer (Maastricht University, Netherlands)

10:25 - 10:45

Understanding the phenotypic changes of vascular smooth muscle cells during atherosclerosis

Jae-Hoon Choi (Hanyang University, Korea)

10:45 - 11:10

Discussion

September 16(Fri)
11:30 - 12:00
Plenary Lecture 2 (APSAVD:Ding Lecture)
September 16(Fri) 11:30 - 12:00
Plenary Lecture 2 (APSAVD:Ding Lecture)

Chairperson

Richard O’Brien (University of Melbourne, Australia)

11:30 - 12:00

Recent developments in the treatment of familial hypercholesterolaemia & other familial lipid disorders

Brian Tomlinson (Macau University of Science & Technology, China)

September 16(Fri)
12:55 - 13:35
Plenary Lecture 3
September 16(Fri) 12:55 - 13:35
Plenary Lecture 3

Chairperson

Goo Taeg Oh (Ewha Womans University, Korea)

12:55 - 13:35

Senescence & vascular smooth muscle cell plasticity

Martin Bennett (University of Cambridge, UK)

September 16(Fri)
13:35 - 15:05
Food and Nutrition Workshop
Cardiometabolic disease & customized nutrition management
September 16(Fri) 13:35 - 15:05
Food and Nutrition Workshop Cardiometabolic disease & customized nutrition management

Chairperson

Myoungsook Lee (Sungshin Women’s University, Korea), Hyojee Joung (Seoul National University, Korea)

Panels

Hyunjung Lim (Kyung Hee University, Korea), Jon Suh (Soonchunhyang University, Korea)

13:35 - 13:55

Customized functional food based on big data

Jiyoung Kim (Seoul National University, Korea)

13:55 - 14:15

Customized prevention of metabolic disease in Koreans using omics technology

Minjoo Kim (Hannam University, Korea)

14:15 - 14:35

Healthcare program using digital health device

Young In Kim (Noom Inc., Korea)

14:35 - 15:00

Discussion

September 16(Fri)
15:15 - 16:15
Oral Presentation 3
September 16(Fri) 15:15 - 16:15
Oral Presentation 3

Chairperson

Sungha Park (Yonsei University, Korea), Hyuk-Sang Kwon (The Catholic University of Korea, Korea)

September 16(Fri)
16:15 - 17:45
Publication Committee Session
September 16(Fri) 16:15 - 17:45
Publication Committee Session

Chairperson

Yong Seek Park (Kyung Hee University, Korea), Jeong-Min Kim (Seoul National University, Korea)

16:15 - 16:20

JLA Award Ceremony

16:20 - 16:35

Regulation of macrophage activation & differentiation in atherosclerosis

Sung Ho Park (Ulsan National Institute of Science and Technology (UNIST), Korea)

16:35 - 16:50

Prospect of artificial intelligence based on electronic medical records

Hun-Sung Kim (Catholic University of Korea, Korea)

16:50 - 17:05

Intravital two-photon imaging of dynamic alteration of lipid droplet in a live animal model

Pilhan Kim (Korea Advanced Institute of Science and Technology (KAIST), Korea)

17:05 - 17:20

Statin therapy & the risk of osteoporotic fractures in patients with metabolic syndrome: a nested case-control study

Kyoung Jin Kim (Korea University, Korea)

17:20 - 17:35

Metabolism & health impacts of dietary sugars

Cholsoon Jang (University of California Irvine, USA)

17:35 - 17:45

Q&A

Breakfast & Luncheon Symposium
September 16(Fri)
08:00 - 09:00
Breakfast Symposium 2 [Organon]
September 16(Fri) 08:00 - 09:00
Breakfast Symposium 2 [Organon]

Chairperson

Seonghoon Choi (Hallym University, Korea)

Panels

Hyemoon Chung (Kyung Hee University, Korea), Bo Kyung Koo (Seoul National University, Korea)

08:00 - 08:20

Management of uric acid in hypertensive patients: role of losartan

Hack-Lyoung Kim (Seoul National University, Korea)

08:20 - 08:30

Discussion

September 16(Fri)
12:00 - 12:50
Luncheon Symposium 4 [JW Pharmaceutical]
September 16(Fri) 12:00 - 12:50
Luncheon Symposium 4 [JW Pharmaceutical]

Chairperson

Jeong Euy Park (Sunkyunkwan University, Korea)

Panels

Bong-Ki Lee (Kangwon National University, Korea), Suk Chon (Kyung Hee University, Korea)

12:00 - 12:20

Cutting edge care of Pitavastatin with Ezetimibe combination therapy

Jun Hwa Hong (Eulji University, Korea)

12:20 - 12:30

Discussion

September 16(Fri)
09:00 - 09:40
Plenary Lecture 1
September 16(Fri) 09:00 - 09:40
Plenary Lecture 1

Chairperson

Donghoon Choi (Yonsei University, Korea)

09:00 - 09:40

Target discovery & drug development for atherosclerosis in 2020's

Sekar Kathiresan (Verve therapeutics, USA)

September 16(Fri)
09:45 - 11:15
Symposium 8
High CV risk group: is it properly defined?
September 16(Fri) 09:45 - 11:15
Symposium 8 High CV risk group: is it properly defined?

Chairperson

Myung-A Kim (Seoul National University, Korea), Woo Je Lee (University of Ulsan, Korea)

Panels

Hack-Lyoung Kim (Seoul National University, Korea), Jung-Joon Cha (Korea University, Korea)

09:45 - 10:05

What is the role of a polygenic risk score in CV risk assessment?

Amit Khera (Verve Therapeutics, USA)

10:05 - 10:25

Refinement of CV risk in current "very high" & "high" risk groups

Hyeon Chang Kim (Yonsei University, Korea)

10:25 - 10:45

Risk stratification according to age groups in new prevention guidelines

Kwang-il Kim (Seoul National University, Korea)

10:45 - 11:10

Discussion

September 16(Fri)
11:30 - 12:00
Plenary Lecture 2 (APSAVD:Ding Lecture)
September 16(Fri) 11:30 - 12:00
Plenary Lecture 2 (APSAVD:Ding Lecture)

Chairperson

Richard O’Brien (University of Melbourne, Australia)

11:30 - 12:00

Recent developments in the treatment of familial hypercholesterolaemia & other familial lipid disorders

Brian Tomlinson (Macau University of Science & Technology, China)

September 16(Fri)
12:55 - 13:35
Plenary Lecture 3
September 16(Fri) 12:55 - 13:35
Plenary Lecture 3

Chairperson

Goo Taeg Oh (Ewha Womans University, Korea)

12:55 - 13:35

Senescence & vascular smooth muscle cell plasticity

Martin Bennett (University of Cambridge, UK)

September 16(Fri)
13:35 - 15:05
Symposium 11
Inflammation in progression & inhibition of atherosclerosis
September 16(Fri) 13:35 - 15:05
Symposium 11 Inflammation in progression & inhibition of atherosclerosis

Chairperson

Hyo-Soo Kim (Seoul National University, Korea), Young-Guen Kwon (Yonsei University, Korea)

Panels

Young-Kook Kim (Chonnam National University, Korea), Chang Hee Jung (University of Ulsan), Korea)

13:35 - 13:55

Macrophage diversity in inflammation & homeostasis

Ichiro Manabe (Chiba University, Japan)

13:55 - 14:15

Inflammation & hematopoiesis in atherosclerosis

Katey Rayner (University of Ottawa, Canada )

14:15 - 14:35

Immune cell repertoire & novel therapeutic target of aortic aneurysm

Seung-Jun Lee (Yonsei University, Korea)

14:35 - 15:00

Discussion

September 16(Fri)
15:15 - 16:15
2022 KSoLA Awards for Scientific Excellence & Young Investigator
Scientific Excellence Award Lecture
September 16(Fri) 15:15 - 16:15
2022 KSoLA Awards for Scientific Excellence & Young Investigator
Scientific Excellence Award Lecture
September 16(Fri)
16:15 - 17:45
Symposium 14 (JAS/KSoLA Joint Symposium)
Impact of aging of vascular cells on atherosclerosis & its protection
September 16(Fri) 16:15 - 17:45
Symposium 14 (JAS/KSoLA Joint Symposium) Impact of aging of vascular cells on atherosclerosis & its protection

Chairperson

Sang Hong Baek (The Catholic University of Korea, Korea), Tohru Minamino (Juntendo University, Japan)

Panels

Kyu-Tae Kim (Ajou University, Korea), Kwang-il Kim (Seoul National University, Korea)

16:15 - 16:35

Aging as risk factor & therapeutic target in atherosclerosis

Sungha Park (Yonsei University, Korea)

16:35 - 16:55

New target genes & molecules for vascular aging

Tohru Minamino (Juntendo University, Japan)

16:55 - 17:15

What effect do cardiovascular medications & diet have on vascular aging?

Kenichi Tsujita (Kumamoto University, Japan)

17:15 - 17:40

Discussion

Breakfast & Luncheon Symposium
September 16(Fri)
12:00 - 12:50
Luncheon Symposium 5 [Viatris]
September 16(Fri) 12:00 - 12:50
Luncheon Symposium 5 [Viatris]

Chairperson

Hyun Ho Shin (Asan Chungmu Hospital, Korea)

Panels

Jun Won Lee (Yonsei University, Korea), Jae-seung Yun (The Catholic University of Korea, Korea)

12:00 - 12:20

What are the optimal treatment options of dyslipidemia management for your
patients? based on LDL-C lowering continuum

So-Yeon Choi (Ajou University, Kroea)

12:20 - 12:30

Discussion

September 16(Fri)
09:45 - 11:15
Symposium 9
Update on non-pharmacological control of ASCVD risk
September 16(Fri) 09:45 - 11:15
Symposium 9
Update on non-pharmacological control of ASCVD risk

Chairperson

Ick Mo Chung (Ewha Womans University , Korea), Sung Nim Han (Seoul National University, Korea)

Panels

Oh Yoen Kim (Dong-A University, Korea), Yeon-Kyung Choi (Kyungpook National University, Korea)

09:45 - 10:05

Exercise & inflammation in atherosclerosis

Matthias Nahrendorf (Harvard Medical School, USA)

10:05 - 10:25

Effect of different diets on circulating lipoproteins

Frank Sacks (Harvard Medical School, USA)

10:25 - 10:45

Trends in dietary quality & cardiometabolic risks among Korean adults

Min-Jeong Shin (Korea University, Korea)

10:45 - 11:10

Discussion

September 16(Fri)
13:35 - 15:05
Symposium 12 (IAS/APSAVD/JAS Joint Symposium)
Dyslipidaemia
September 16(Fri) 13:35 - 15:05
Symposium 12 (IAS/APSAVD/JAS Joint Symposium)
Dyslipidaemia

Chairperson

Richard O’Brien (University of Melbourne, Australia), Jaetaek Kim (Chung-Ang University, Korea)

Panels

Jae Hyuk Lee (Myongji Hospital, Korea), Seung Jin Han (Ajou University, Korea)

13:35 - 13:55

Dyslipidaemia - new treatments for ApoC3 & ANGPTL3

Brian Tomlinson (Macau University of Science & Technology, China)

13:55 - 14:15

Novel selective PPARa modulator pemafibrate for dyslipidemia & nonalcoholic fatty liver disease (NAFLD)

Shizuya Yamashita (Rinku General Medical Center, Japan)

14:15 - 14:35

New treatment targets beyond LDL-C in dyslipidaemias

Alberico Catapano (University of Milan, Italy)

14:35 - 15:00

Discussion

September 16(Fri)
16:15 - 17:45
Symposium 15 (APSAVD/KSoLA Joint Symposium)
COVID-19 & cardiovascular risk
September 16(Fri) 16:15 - 17:45
Symposium 15 (APSAVD/KSoLA Joint Symposium)
COVID-19 & cardiovascular risk

Chairperson

Young-Bae Park (Seoul National University, Korea), Edward Janus (University of Melbourne, Austrailia)

Panels

Hong Nyun Kim (Kyungpook National University, Korea), Jung Ho Heo (Kosin University, Korea)

16:15 - 16:35

Impact of risk factors & medications on COVID-19 outcomes

In Sook Kang (Ewha Womans University, Korea)

16:35 - 16:55

Effect of COVID-19 on dyslipidemia & vascular disease

Edward Janus (University of Melbourne, Australia)

16:55 - 17:15

Benefit & harm of COVID-19 vaccines in ASCVD

Ta-Chen Su (National Taiwan University, Taiwan)

17:15 - 17:40

Discussion

Breakfast & Luncheon Symposium
September 16(Fri)
12:00 - 12:50
Luncheon Symposium 6 [Boehringer Ingelheim/Lilly]
September 16(Fri) 12:00 - 12:50
Luncheon Symposium 6 [Boehringer Ingelheim/Lilly]

Chairperson

Shung Chull Chae (Kyungpook National University, Korea)

Panels

Hye-Mi Kim (Chung-Ang University, Korea), Yeoree Yang (The Catholic University of Korea, Korea)

September 17(Sat)
09:00 - 09:40
Plenary Lecture 4
September 17(Sat) 09:00 - 09:40
Plenary Lecture 4

Chairperson

Joong-Yeol Park (University of Ulsan, Korea)

09:00 - 09:40

New look at PCSK9 metabolism & its clinical implication

Sergio Fazio (Regeneron Pharmaceuticals, USA)

September 17(Sat)
09:45 - 11:15
Symposium 16
Current issues in severe dyslipidemia
September 17(Sat) 09:45 - 11:15
Symposium 16 Current issues in severe dyslipidemia

Chairperson

Hyun Jae Kang (Seoul National University, Korea), Kyung Mook Choi (Korea University, Korea)

Panels

Soo Heon Kwak (Seoul National University, Korea), Young Sup Byun (Inje University, Korea)

09:45 - 10:05

What is currently best & changing in treatment of adults with FH?

Wonjae Lee (Seoul National University, Korea)

10:05 - 10:25

Update on familial vs mulitifactorial chylomicronemia syndrome

Heung Yong Jin (Jeonbuk National University, Korea)

10:25 - 10:45

Understanding role of ANGPTL3 & neighbor molecules

Hun-Jun Park (The Catholic University of Korea, Korea)

10:45 - 11:10

Discussion

September 17(Sat)
11:25 - 12:05
Plenary Lecture 5
September 17(Sat) 11:25 - 12:05
Plenary Lecture 5

Chairperson

Ki Hoon Han (University of Ulsan, Korea)

11:25 - 12:05

Best approach to cardio & cerebrovascular health in the elderly

Hidenori Arai
(National Center for Geriatrics and Gerontology, Japan)

September 17(Sat)
13:00 - 13:30
Plenary Lecture 6 (APSAVD:Yamamoto Lecture)
September 17(Sat) 13:00 - 13:30
Plenary Lecture 6 (APSAVD:Yamamoto Lecture)

Chairperson

Richard O’Brien (University of Melbourne, Australia)

13:00 - 13:30

Up close & personal with vascular diseases: the role of precision medicine

Maria Teresa Abola (University of Philippines, Philippines)

September 17(Sat)
13:35 - 14:35
Oral Presentation 4
September 17(Sat) 13:35 - 14:35
Oral Presentation 4

Chairperson

Kyung-Sun Heo (Chungnam National University, Korea)

September 17(Sat)
14:45 - 16:15
Symposium 20
How will new technologies change our research & patient care in ASCVD?
September 17(Sat) 14:45 - 16:15
Symposium 20
How will new technologies change our research & patient care in ASCVD?

Chairperson

Seung Hwan Han (Gachon Universtiy, Korea), Dae Jung Kim (Ajou University, Korea)

Panels

Yongsung Suh (Myongji Hospital, Korea), Ji-won Hwang (Inje University, Korea)

14:45 - 15:05

Tips for performing nationwide big cohort studies

Pil-Sung Yang (Cha University, Korea)

15:05 - 15:25

Advance of AI utility in past 5 years in ASCVD care: overview

Jun Hwan Cho (Chung-Ang University, Korea)

15:25 - 15:45

Device-based care for CV risk factors

Hak Seung Lee (Medical AI, Korea)

15:45 - 16:10

Discussion

Breakfast & Luncheon Symposium
September 17(Sat)
08:00 - 09:00
Breakfast Symposium 3 [Yuhan]
September 17(Sat) 08:00 - 09:00
Breakfast Symposium 3 [Yuhan]

Chairperson

Tae Seo Son (The Catholic University of Korea, Korea)

Panels

Jeong Su Kim (Pusan National University, Korea)

08:00 - 08:20

Lipid management : to the perfection & state of art

Hyo In Choi (Sunkyunkwan University, Kroea)

08:20 - 08:30

Discussion

September 17(Sat)
12:05 - 12:55
Luncheon Symposium 7 [Inno.N]
September 17(Sat) 12:05 - 12:55
Luncheon Symposium 7 [Inno.N]

Chairperson

Hyun Chul Lee (Yonsei University, Korea)

Panels

Hyung Bok Park (Catholic Kwandong University, Korea), Mi Hye Seo (Soonchunhyang University, Korea)

12:05 - 12:25

Treatment of dyslipidemia with rosuvastatin & ezetimibe

Sang-Hyun Kim (Seoul National University, Korea)

12:25 - 12:35

Discussion

September 17(Sat)
09:00 - 09:40
Plenary Lecture 4
September 17(Sat) 09:00 - 09:40
Plenary Lecture 4

Chairperson

Joong-Yeol Park (University of Ulsan, Korea)

09:00 - 09:40

New look at PCSK9 metabolism & its clinical implication

Sergio Fazio (Regeneron Pharmaceuticals, USA)

September 17(Sat)
09:45 - 11:15
Symposium 17
Emerging targets & drug platforms in dyslipidemia & atherosclerosis
September 17(Sat) 09:45 - 11:15
Symposium 17 Emerging targets & drug platforms in dyslipidemia & atherosclerosis

Chairperson

Kyong Soo Park (Seoul National University, Korea), Alan Remaley (National Institute of Health, USA)

Panels

Chang-Hoon Woo (Yeungnam University, Korea), Gyuri Kim (Sunkyunkwan University, Korea)

09:45 - 10:05

Impact of lipases on human dyslipidemia & atherosclerosis

Hayato Tada (Kanazawa University, Japan)

10:05 - 10:25

Discover of new genes involved in low-density lipoprotein metabolism by genome-wide CRISPR-Cas9 screens

Alan Remaley (National Institutes of Health, USA)

10:25 - 10:45

Understanding strength & limitation of platforms in drug development

Dong Ki Lee (OliX Pharmaceuticals, Korea)

10:45 - 11:10

Discussion

September 17(Sat)
11:25 - 12:05
Plenary Lecture 5
September 17(Sat) 11:25 - 12:05
Plenary Lecture 5

Chairperson

Ki Hoon Han (University of Ulsan, Korea)

11:25 - 12:05

Best approach to cardio & cerebrovascular health in the elderly

Hidenori Arai
(National Center for Geriatrics and Gerontology, Japan)

September 17(Sat)
13:00 - 13:30
Plenary Lecture 6 (APSAVD:Yamamoto Lecture)
September 17(Sat) 13:00 - 13:30
Plenary Lecture 6 (APSAVD:Yamamoto Lecture)

Chairperson

Richard O’Brien (University of Melbourne, Australia)

13:00 - 13:30

Up close & personal with vascular diseases: the role of precision medicine

Maria Teresa Abola (University of Philippines, Philippines)

September 17(Sat)
13:35 - 14:35
Oral Presentation 5
September 17(Sat) 13:35 - 14:35
Oral Presentation 5

Chairperson

Eun Seok Kang (Yonsei University, Korea)

September 17(Sat)
14:45 - 16:15
Symposium 21
New concepts in vascular biology
September 17(Sat) 14:45 - 16:15
Symposium 21 New concepts in vascular biology

Chairperson

Chi Dae Kim (Pusan National University, Korea), Hyun Kook (Chonnam National University, Korea)

Panels

Jin Hur (Pusan National University, Korea), Eun Sun Jin (Kyung Hee University, Korea)

14:45 - 15:05

What's new in vascular calcification in atherosclerosis?

In-Kyu Lee (Kyungpook National University, Korea)

15:05 - 15:25

Cellular senescence in atherosclerosis

Jae-Ryong Kim (Yeungnam University, Korea)

15:25 - 15:45

Extracellular vesicles & endothelial cells

Kihwan Kwon (Ewha Womans University, Korea)

15:45 - 16:10

Discussion

Breakfast & Luncheon Symposium
September 17(Sat)
08:00 - 09:00
Breakfast Symposium 4 [JW Pharmaceutical]
September 17(Sat) 08:00 - 09:00
Breakfast Symposium 4 [JW Pharmaceutical]

Chairperson

Ung Kim (Yeungnam University, Korea)

Panel

JaeHyuk Choi (Hallym University, Korea)

08:00 - 08:20

Management of poorly controlled patients with diabetes mellitus

Yongho Lee (Yonsei University, Korea)

08:20 - 08:30

Discussion

September 17(Sat)
12:05 - 12:55
Luncheon Symposium 8 [Hanmi]
September 17(Sat) 12:05 - 12:55
Luncheon Symposium 8 [Hanmi]

Chairperson

Hong-Seog Seo (Korea University, Korea)

Panels

Byung Gyu Kim (Inje University, Korea), Yun Kyung Cho (University of Ulsan, Korea)

12:05 - 12:25

Why should we consider rosuvastatin + ezetimibe fixed dose combination

Seung-Woon Rha (Korea University, Korea)

12:25 - 12:35

Discussion

September 17(Sat)
09:00 - 09:40
Plenary Lecture 4
September 17(Sat) 09:00 - 09:40
Plenary Lecture 4

Chairperson

Joong-Yeol Park (University of Ulsan, Korea)

09:00 - 09:40

New look at PCSK9 metabolism & its clinical implication

Sergio Fazio (Regeneron Pharmaceuticals, USA)

September 17(Sat)
09:45 - 11:15
Symposium 18
Role & unsolved issues of novel lipid-modifying agents
September 17(Sat) 09:45 - 11:15
Symposium 18 Role & unsolved issues of novel lipid-modifying agents

Chairperson

Soo Lim (Seoul National University, Korea), Byung Jin Kim (Sungkyunkwan University, Korea)

Panels

Jang Hoon Lee (Kyungpook National University, Korea), Min Kyong Moon (Seoul National University, Korea)

09:45 - 10:05

Challenges & perspective of drugs for Lp(a)

Gisette Reyes-Soffer (Columbia University, USA)

10:05 - 10:25

For whom & how much will bempedoic acid work?

Raul Santos (University of São Paulo, Brazil)

10:25 - 10:45

Recent trial results of new drugs targeting TG rich lipoprotein

Eun Ho Choo (The Catholic University of Korea, Korea)

10:45 - 11:10

Discussion

September 17(Sat)
11:25 - 12:05
Plenary Lecture 5
September 17(Sat) 11:25 - 12:05
Plenary Lecture 5

Chairperson

Ki Hoon Han (University of Ulsan, Korea)

11:25 - 12:05

Best approach to cardio & cerebrovascular health in the elderly

Hidenori Arai
(National Center for Geriatrics and Gerontology, Japan)

September 17(Sat)
13:00 - 13:30
Plenary Lecture 6 (APSAVD:Yamamoto Lecture)
September 17(Sat) 13:00 - 13:30
Plenary Lecture 6 (APSAVD:Yamamoto Lecture)

Chairperson

Richard O’Brien (University of Melbourne, Australia)

13:00 - 13:30

Up close & personal with vascular diseases: the role of precision medicine

Maria Teresa Abola (University of Philippines, Philippines)

September 17(Sat)
14:45 - 16:15
Symposium 22 (TSLA/KSoLA Joint Symposium)
Sex difference in dyslipidemia & atherosclerosis
September 17(Sat) 14:45 - 16:15
Symposium 22 (TSLA/KSoLA Joint Symposium) Sex difference in dyslipidemia & atherosclerosis

Chairperson

Chul Sik Kim (Yonsei University, Korea), Sang-Hyun Kim (Seoul National University, Korea)

Panels

Sang Min Park (Eulji University, Korea), Sung-Eun Kim (Hallym University, Korea)

14:45 - 15:05

Characteristics of dyslipidemia & ASCVD of women

Mi-Na Kim (Korea University, Korea)

15:05 - 15:25

Sex difference in diagnosis & treatment of ASCVD: what do we need to improve in women?

Ping-Yen Liu (National Cheng Kung University, Taiwan)

15:25 - 15:45

Is there difference of response to lipid-lowering therapy in women?

Chih-Fan Yeh (National Taiwan University, Taiwan)

15:45 - 16:10

Discussion

Breakfast & Luncheon Symposium
September 17(Sat)
12:05 - 12:55
Luncheon Symposium 9 [Amgen]
September 17(Sat) 12:05 - 12:55
Luncheon Symposium 9 [Amgen]

Chairperson

Kyong Soo Park (Seoul National University, Korea)

Panels

Choongki Kim (Ewha Womans University, Korea), EuJeong Ku (Chungbuk National University, Korea)

12:05 - 12:25

Key updates in the recent guidelines – identifying patients for evolocumab therapy

Wonjae Lee (Seoul National University, Korea)

12:25 - 12:35

Discussion

September 17(Sat)
09:45 - 11:15
Symposium 19
Current nutritional knowledge in cardiometabolic health
September 17(Sat) 09:45 - 11:15
Symposium 19 Current nutritional knowledge in cardiometabolic health

Chairperson

Ji-Young Lee (University of Connecticut, USA), Kee Ho Song (Konkuk University, Korea)

Panels

In-Jeong Cho (Ewha Womans University, Korea), Jeong-Hwa Choi (Keimyung University, Korea)

09:45 - 10:05

Organ crosstalk under atherogenic diet

Cholsoon Jang (University of California Irvine, USA)

10:05 - 10:25

Emerging role of epigenetic regulation by nutrients in inflammation & atherosclerosis

Hyunju Kang (Keimyung University, Korea)

10:25 - 10:45

Transition to metabolically unhealthy status & cardiometabolic risks

Clara Yongjoo Park (Chonnam National University, Korea)

10:45 - 11:10

Discussion

September 17(Sat)
14:45 - 16:15
Symposium 23 (APSAVD Joint Symposium)
Update on antibodies & siRNA against PCSK9
September 17(Sat) 14:45 - 16:15
Symposium 23 (APSAVD Joint Symposium)
Update on antibodies & siRNA against PCSK9

Chairperson

In-Kyung Jeong (Kyung Hee University, Korea), TBD (APSAVD)

Panels

Hyun Jae Kang (Seoul National University, Korea), Jong-Young Lee (Sungkyunkwan University, Korea)

14:45 - 15:05

Practical approach of PCSK9 Ab use in primary & secondary prevention

Young Joon Hong (Chonnam National University, Korea)

15:05 - 15:25

Comparison of two drug platforms (Abs & siRNA)

Richard O’Brien (University of Melbourne, Australia)

15:25 - 15:45

Patients who are resistant to or hypo-respond to PCSK9 inhibitors – a therapeutic challenge

Edward Janus (University of Melbourne, Australia)

15:45 - 16:10

Discussion

Breakfast & Luncheon Symposium
September 17(Sat)
12:05 - 12:55
Luncheon Symposium 10 [Sanofi]
September 17(Sat) 12:05 - 12:55
Luncheon Symposium 10 [Sanofi]

Chairperson

Kwang Kon Koh (K-Heart Clinic & Lab, Korea)

Panels

Sang-Hun Shin (Ewha Womans University, Korea), Jae Hyun Bae (Korea University, Korea)

12:05 - 12:25

The time for intensive LLT in very high-risk patients based on the updated Korean guideline

Hoyoun Won (Chung-Ang University, Korea)

12:25 - 12:35

Discussion

Sponsored by